Human Influenza: Clinical Trials

5 trials for Human Influenza, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 21Completed 1

Follow Human Influenza: new trials by email Literature Review of Human Influenza trials Research Report on Human Influenza

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine
influenza vaccine - Human Influenza
Phase 3CompletedResearch Institute for Biological Safety Problems20002017-09-182018-06-28
Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents
Vaccination with Fluval AB Novo suspension for injection, half dose of a single intramuscular dose (0.25 ml), Vaccination with Fluval AB Novo suspension for injection, single intramuscular dose (0.5 ml) - Human Influenza
Phase 3CompletedFluart Innovative Vaccine Ltd, Hungary1202014-10-012021-03-11
Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above
TIVf - Human Influenza
Phase 3CompletedNovartis Vaccines1252013-08-012014-03-12
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above
TIVc - Human Influenza
Phase 3CompletedNovartis Vaccines1262013-08-012017-02-23
Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.
Enisamium Iodide, Placebo - Acute Respiratory Viral Infections, Human Influenza
Phase 2 / Phase 3CompletedJoint Stock Company "Farmak"1002009-04-132026-01-08

Narrower conditions

Influenza, Human (5)  ·  Virus Diseases (1)

Broader conditions

Infections (5)  ·  Orthomyxoviridae Infections (5)  ·  RNA Virus Infections (5)  ·  Respiratory Tract Diseases (5)  ·  Respiratory Tract Infections (5)  ·  Virus Diseases (4)

Interventions

Influenza Vaccines (1)  ·  Injections (1)  ·  Vaccination (1)  ·  enisamium iodide (1)

Sponsors

Novartis Vaccines (2)  ·  Fluart Innovative Vaccine Ltd, Hungary (1)  ·  Joint Stock Company "Farmak" (1)  ·  Research Institute for Biological Safety Problems (1)

Countries

Germany (2)  ·  Kazakhstan (1)

Top investigators

Ekatarina A. Okhapkina (1)

Results publications

PMID 33558285